2015 myresearch Science Internship Program: Nursing Care. Civic Education Office of Government and Community Relations
|
|
- Ursula Hudson
- 5 years ago
- Views:
Transcription
1 2015 myresearch Science Internship Program: Nursing Care Civic Education Office of Government and Community Relations
2 Mary Chudy Science Internship Program: Nursing Care
3 Patients with a Deep Brain Stimulator who Received Ketamine for Treatment Resistant Depression: A Case Study Mary Chudy Nora Finnegan, RN, BSN
4 Abstract About 50% of people do not respond to medications and therapy. Deep brain stimulation (DBS) involves sending electrical impulses to the brain. DBS, along with ketamine, are two treatments that help alleviate depressive symptoms. This study looked at 3 patients with TRD who had DBS and were being treated with ketamine. If one has an implanted DBS, ketamine infusions will not successfully treat them.
5 Background In a given year, about 14 million Americans will experience an episode of MDD. Of those that receive treatment (30%) 50% will not respond. Two+ failed treatment attempts lowers likelihood of remission. Consider diagnosis of TRD
6 Background Ketamine is a dissociative anesthetic used in veterinary medicine. In sub-anesthetic doses, it provides relief for patients with TRD. 0.5 mg/kg over 40 minutes with saline bolus following Targets the NMDA receptor complex inhibitory GABA
7 Background Deep Brain Stimulation to certain neuroanatomical sites has also been found to alleviate symptoms. Small electrical impulses trigger increased brain activity.
8 Problem/Purpose Provide clinical evidence on the efficacy of ketamine treatments in patients with DBS Explore the biochemical pathways of both ketamine and DBS in relation to each other Synthesize whether the presence of a DBS indicates or contraindicates ketamine
9 Hypothesis If ketamine patients have a pre-existing functioning deep brain stimulator then they will Respond later than patients normally would (24 hrs) Experience a lessened response to the ketamine infusions Ultimately need to withdraw from the ketamine treatments due to lack of response
10 Methodology Retrospective study medical chart review on 3 patients who fit criteria Receiving/have received a series of ketamine infusions Functional, implanted DBS in use Charts compared to those w/o DBS Indications for ketamine 2 or more failed antidepressants in 2+ classes ECT produced no response No major head trauma or psychosis
11 MADRS Score Data Treatment # Downward trend demonstrates ketamine s efficacy.
12 MADRS Score Data Patient MADRS Scores During Ketamine Treatment # Initial, transient drop in MADRS. No lasting effect.
13 Results A MADRS score of <8 maintained for 3-4 weeks= depression in remission. Pt 1: responder- 9 Pt 2: non-responder Pt 3: non-responder- 21.5
14 Conclusions Hypothesis supported by results If patient with DBS is being treated with ketamine Will experience lessened degree of alleviation Longer than average acute series Transient response Eventual regression to original state
15 Recommendations Larger sample size to further confirm these results Further research on the biochemical mechanism of deep brain stimulation Healthcare organizations educate on the possibility to treat TRD with sub-anesthetic doses of ketamine Further research on the NMDA receptor complex
16 References Bogod, N. (n.d.). Long-Term Neuropsychological Safety of Subgenual Cingulate Gyrus Deep Brain Stimulation for Treatment-Resistant Depression. Retrieved July 13, 2015, from The Journal of Neuropsychiatry website: Deep Brain Stimulation to Reward Circuitry Alleviates Anhedonia in Refractory Major Depression. (n.d.). Neuropsychopharacology. (including photos slide 7, 14). lkennedy, S. (n.d.). Deep Brain Stimulation for Treatment-Resistant Depression: Follow-Up After 3 to 6 Years. Retrieved July 12, 2015, from Long-Term Effects of Nucleus Accumbens Deep Brain Stimulation in Treatment-Resistant Depression: Evidence for Sustained Efficacy. (n.d.). Retrieved from Neuropsychopharmacology website:
17 Special Thanks Nora Finnegan, RN, BSN Roman Dale, MD Lawre Stratton, RN The entire staff of Behavioral Health at Lutheran Hospital Nedra Starling, MA, MPH, ABD/DrPH and the Civic Education Department My amazing peer group and fellow peer mentors
18 Copyright 2015 Cleveland Clinic Foundation
2018 myresearch Science Internship Program: Health Horizons. Civic Education Office of Government and Community Relations
2018 myresearch Science Internship Program: Health Horizons Civic Education Office of Government and Community Relations Amnerys Camacho Science Internship Program: Health Horizons Alternative Treatments
More information2016 myresearch Science Internship Program: Applied Medicine. Civic Education Office of Government and Community Relations
2016 myresearch Science Internship Program: Applied Medicine Civic Education Office of Government and Community Relations Nadia Paskert Science Internship Program: Applied Medicine Breast Reconstruction
More information2016 myresearch Science Internship Program: Radiology. Civic Education Office of Government and Community Relations
2016 myresearch Science Internship Program: Radiology Civic Education Office of Government and Community Relations Kayla Siladi Science Internship Program: Radiology Pediatric Computed Tomography Scans
More information2016 myresearch Science Internship Program: Laboratory Medicine. Civic Education Office of Government and Community Relations
2016 myresearch Science Internship Program: Laboratory Medicine Civic Education Office of Government and Community Relations Aliya Ansari Science Internship Program: Laboratory Medicine Cytologic Differentiation
More information2013 myresearch Science Internship Program for Nursing
2013 myresearch Science Internship Program for Nursing Tamarea Townes Science Internship Program for Nursing An Investigation of Risk Factors Associated with Hypoglycemia in Adult Hospitalized Patients
More information2014 myresearch SCIENCE Internship Program
2014 myresearch SCIENCE Internship Program Maya Gaines-Smith Science Internship Program Does Mobilization of Patients With a Cancer Diagnosis Decrease Pain? Maya Gaines-Smith Marianne Douglas, MS CCC/SLP
More information2013 myresearch Public Health Internship Program
2013 myresearch Public Health Internship Program Joo Kim Public Health Internship Program Open Repair: Significance of Mesh Type on Inguinal Herniorrhaphy Joo Kim Richard T. Guttman Jr., MD, FACS Abstract
More information2017 myresearch Science Internship Program: Applied Medicine. Civic Education Office of Government and Community Relations
2017 myresearch Science Internship Program: Applied Medicine Civic Education Office of Government and Community Relations Nevaeh Miller Science Internship Program: Applied Medicine A Combined Spiral CT
More informationNeural model of emotional regulation structures - Circuits involving prefrontal cortex and subcortical limbic structures - MDE associated with
Topics Brain and signalling changes in depression Ketamine activity in refractory depression Mechanism of Action New Data Dose finding Route of Administration Activity in Other Disorders Neural model of
More information2013 myresearch Science Internship Program
2013 myresearch Science Internship Program Ryan Palko Science Internship Program Association and Frequency of Antithyroid Antibodies in Fibromyalgia Cohort at the Cleveland Clinic Ryan Palko Mehrnaz Hojjati
More information2015 myresearch Science Internship Program: Applied Medicine. Civic Education Office of Government and Community Relations
2015 myresearch Science Internship Program: Applied Medicine Civic Education Office of Government and Community Relations Harguneet Singh Science Internship Program: Applied Medicine Comparisons of Outcomes
More informationPsychotropic Drugs in the Pipeline. Norman Sussman, M.D. Professor of Psychiatry New York University School of Medicine
Psychotropic Drugs in the Pipeline Norman Sussman, M.D. Professor of Psychiatry New York University School of Medicine Norman Sussman, MD No Conflict of Interest to Declare Antidepressant Pipeline We need
More informationClinical Perspective on Conducting TRD Studies. Hans Eriksson, M.D., Ph.D., M.B.A. Chief Medical Specialist, H. Lundbeck A/S Valby, Denmark
Clinical Perspective on Conducting TRD Studies Hans Eriksson, M.D., Ph.D., M.B.A. Chief Medical Specialist, H. Lundbeck A/S Valby, Denmark Overview of Presentation Treatment-Resistant Depression (TRD)
More informationBrain Stimulation. Berry S. Anderson, PhD, RN Mary Rosedale, PhD, PMHNP-BC, NEA-BC Theresa Kormos, PMHCNS-BC Cindy Brown, BSN, RN
Brain Stimulation American Psychiatric Nurses Association 24th Annual Conference October 16, 2010 Kentucky International Convention Center Louisville, Kentucky 1 Berry S. Anderson, PhD, RN Mary Rosedale,
More informationObjectives. Objectives. A practice review. 02-Nov-16 MAJOR DEPRESSIVE DISORDER: NEW DEVELOPMENTS AND PRACTICAL IMPLICATIONS
MAJOR DEPRESSIVE DISORDER: NEW DEVELOPMENTS AND PRACTICAL IMPLICATIONS Jon-Paul Khoo What is treatment resistance really? Database review 328 consecutive non-remitted MDD patients referred for private
More informationA preliminary naturalistic study of low-dose ketamine for depression and suicide ideation in the emergency department
International Journal of Neuropsychopharmacology (2011), 14, 1127 1131. f CINP 2011 doi:10.1017/s1461145711000629 A preliminary naturalistic study of low-dose ketamine for depression and suicide ideation
More informationClinical Policy Title: Ketamine for treatment-resistant depression
Clinical Policy Title: Ketamine for treatment-resistant depression Clinical Policy Number: 00.02.13 Effective Date: January 1, 2016 Initial Review Date: August 19, 2015 Most Recent Review Date: January
More informationClinical Commissioning Policy: Deep Brain Stimulation for Refractory Epilepsy
Clinical Commissioning Policy: Deep Brain Stimulation for Refractory Epilepsy Reference: NHS England xxx/x/x 1 Clinical Commissioning Policy: Deep Brain Stimulation for Refractory Epilepsy First published:
More informationNeuromodulation Approaches to Treatment Resistant Depression
1 Alternative Treatments: Neuromodulation Approaches to Treatment Resistant Depression Audrey R. Tyrka, MD, PhD Assistant Professor Brown University Department of Psychiatry Associate Chief, Mood Disorders
More informationIV Ketamine Infusions for the Treatment of Depression: An Evidence Based Practice Analysis Sergio A. Quinones, SRNA Bryan College of Health Sciences
IV Ketamine Infusions for the Treatment of Depression: An Evidence Based Practice Analysis Sergio A. Quinones, SRNA Bryan College of Health Sciences Keywords: ketamine, depression, antidepressant, infusion,
More informationDepartment of Psychiatry AG Stimulationsverfahren in der Psychiatrie. The Role of Ketamine in Treatment-Resistant Depression
Department of Psychiatry AG Stimulationsverfahren in der Psychiatrie The Role of Ketamine in Treatment-Resistant Depression Dr. Heiko Albrecht The Role of Ketamine in Treatment-Resistant Depression 2 Presentation
More informationUnderstanding Addiction: Why Can t Those Affected Just Say No?
Understanding Addiction: Why Can t Those Affected Just Say No? 1 The Stigma of Addiction There continues to be a stigma surrounding addiction even among health care workers. Consider the negative opinions
More informationBehavior Therapy. Therapy that applies learning principles to the elimination of unwanted behaviors.
Behavior Therapy Therapy that applies learning principles to the elimination of unwanted behaviors. To treat phobias or sexual disorders, behavior therapists do not delve deeply below the surface looking
More informationAnatomy of a Neuron. Copyright 2000 by BSCS and Videodiscovery, Inc. Permission granted for classroom use. Master 2.1
Anatomy of a Neuron Master 2.1 Neurons Interact With Other Neurons Through Synapses Master 2.2 How Do Neurons Communicate? 1 2 3 4 5 6 Master 2.3 Neurons Communicate by Neurotransmission Neurons communicate
More informationTreatment Algorithm Treatment Algorithm
Treatment Algorithm Treatment Algorithm Primary Care Toolkit September 2015 Page 2 Adult (>18 years) Depression Flow Chart (Generic) Two Question Screen: PHQ-2 Annually, new adult patients, and when suspect
More information#CHAIR2016. September 15 17, 2016 The Biltmore Hotel Miami, FL. Sponsored by
#CHAIR2016 September 15 17, 2016 The Biltmore Hotel Miami, FL Sponsored by #CHAIR2016 Ketamine: Promising Path or False Prophecy in the Development of Novel Therapeutics for Mood Disorders Alan F. Schatzberg,
More informationPhysical and Physiological Aspects of Drug Use and Abuse
Question 1: What are neurons and neurotransmitters? Answer 1: A neuron is a nerve cell. It is estimated that there are 100 billion neurons in the average human brain (Levinthal, 2008). Neurons receive
More informationEpilepsy CASE 1 Localization Differential Diagnosis
2 Epilepsy CASE 1 A 32-year-old man was observed to suddenly become unresponsive followed by four episodes of generalized tonic-clonic convulsions of the upper and lower extremities while at work. Each
More informationFrequently Asked Questions FAQS. NeuroStar TMS Therapies
Frequently Asked Questions FAQS NeuroStar TMS Therapies Provided by Dr Terrence A. Boyadjis MD 790 E Market Street Suite 245 West Chester, PA 19382 610.738.9576 FAQS About TMS Therapies Page 1 NeuroStar
More informationNeurobiology of Addiction JeanAnne Johnson Talbert, DHA, APRN BC, FNP, CARN AP
Neurobiology of Addiction JeanAnne Johnson Talbert, DHA, APRN BC, FNP, CARN AP Disclosures This speaker has no conflicts of interest to disclose Objectives Define drug abuse and addiction Identify the
More informationGoals for sedation during mechanical ventilation
New Uses of Old Medications Gina Riggi, PharmD, BCCCP, BCPS Clinical Pharmacist Trauma ICU Jackson Memorial Hospital Disclosure I do not have anything to disclose Objectives Describe the use of ketamine
More informationAddressing Emergency Neuro- Pharmacologic Controversies Head-On. What dose of IV benzodiazepine makes you uncomfortable?
Addressing Emergency Neuro- Pharmacologic Controversies Head-On 38 y/o 136 bpm Bryan D. Hayes @PharmERToxGuy Sz, tremor, hallucinations Which benzodiazepine would you administer first? Why? Diazepam Lorazepam
More informationHelp and Healing: Section 2: Treatment Planning. Treatment and Timelines. Depression Treatment Reference. Care Team Communication
Help and Healing: Resources for Depression Care and Recovery Section 2: Treatment Planning Treatment and Timelines Depression Treatment Reference Care Team Communication Provider Education Tool - Questions
More informationInterventions for Relapsing Depression: TMS, ECT, and Ketamine
Interventions for Relapsing Depression: TMS, ECT, and Ketamine MDD top cause of disability; suicide only top-10 cause of death currently increasing. 10-15% lifetime prevalence A third of patients do not
More informationInterventions for Relapsing Depression: TMS, ECT, and Ketamine
Interventions for Relapsing Depression: TMS, ECT, and Ketamine MDD top cause of disability; suicide only top-10 cause of death currently increasing. 10-15% lifetime prevalence A third of patients do not
More informationSpecific Care Question : Question Originator: Plain Language Summary from The Office of Evidence Based Practice: Conditional Recommendation
Ketorolac for Refractory Migraine in the ED Specific Care Question : In the pediatric patient diagnosed with refractory migraine is ketorolac an effective treatment? Question Originator: Migraine Therapy
More informationThe Evidence Base for rtms Reimbursement
The Evidence Base for rtms Reimbursement Bradley N. Gaynes, MD, MPH Professor of Psychiatry Associate Chair of Research Training and Education Institute of Medicine Workshop March 3, 2015 What do we know,
More informationNew Research on ECT and development of neuromodulation for treatment of depression
New Research on ECT and development of neuromodulation for treatment of depression Kaisa M. Hartikainen Neurologist, Academy Research Fellow, Associate Professor of Experimental Neurology Behavioral Neurology
More informationPossession by evil spirits? Demon rum. Lack of moral fiber? War on drugs Just say no
Dr. Joseph Garbely Medical Director VP of Medical Services Caron Treatment Centers 1 ASAM Disclosure of Relevant Financial Relationships No Relevant Financial Relationships with Any Commercial Interests
More informationDeep Brain Stimulation for Treatment-Resistant Depression: A Review
The Open Neurosurgery Journal, 2011, 4, 1-6 1 Open Access Deep Brain Stimulation for Treatment-Resistant Depression: A Review Tatyana Sarnecki* and Yasin Temel* Departments of Neuroscience and Neurosurgery,
More informationSUPPLEMENTARY INFORMATION
Supplementary Figure 1. Behavioural effects of ketamine in non-stressed and stressed mice. Naive C57BL/6 adult male mice (n=10/group) were given a single dose of saline vehicle or ketamine (3.0 mg/kg,
More informationResults of a one-year, retrospective medication use evaluation. Joseph Ladd, PharmD PGY-1 Pharmacy Resident BHSF Homestead Hospital
Results of a one-year, retrospective medication use evaluation Joseph Ladd, PharmD PGY-1 Pharmacy Resident BHSF Homestead Hospital Briefly review ketamine s history, mechanism of action, and unique properties
More informationKetamine as a Potential Treatment for Suicidal Ideation: A Systematic Review of the Literature
Drugs R D (2015) 15:37 43 DOI 10.1007/s40268-015-0081-0 REVIEW ARTICLE Ketamine as a Potential Treatment for Suicidal Ideation: A Systematic Review of the Literature Lael Reinstatler Nagy A. Youssef Published
More informationCarlos A. Zarate, Jr., M.D
Performing valid analysis in sex differences and treatment response in depression vs. Multi-modal imaging and psychiatric stress testing: A strategy for translational psychopharmacology in mood disorders
More informationThe Neurobiology of Addiction
The Neurobiology of Addiction Jodi Gilman, Ph.D. Center for Addiction Medicine Massachusetts General Hospital Associate Professor, Department of Psychiatry Harvard Medical School What is Addiction? commonly
More informationSurgical Treatment of Movement Disorders. Surgical Treatment of Movement Disorders. New Techniques: Procedure is safer and better
Surgical Treatment of Movement Stephen Grill, MD, PHD Johns Hopkins University and Parkinson s and Movement Center of Maryland Surgical Treatment of Movement Historical Aspects Preoperative Issues Surgical
More informationLife in the Fast Lane: Rapidly Acting Agents Acute Care Research
Life in the Fast Lane: Rapidly Acting Agents Acute Care Research Cheryl McCullumsmith, MD PhD i Disclosures Consultant, Advisory Board Janssen Grants :American Foundation for Suicide Prevention Janssen
More informationMEDICAL POLICY SUBJECT: KETAMINE INFUSION THERAPY FOR THE TREATMENT OF CHRONIC PAIN SYNDROMES POLICY NUMBER: CATEGORY: Technology Assessment
Clinical criteria used to make utilization review decisions are based on credible scientific evidence published in peer reviewed medical literature generally recognized by the medical community. Guidelines
More informationAP PSYCH Unit 13.3 Biomedical Therapies
AP PSYCH Unit 13.3 Biomedical Therapies Prescribed medications or medical procedures that act directly on the patient s nervous system. Drugs that alter brain chemistry Affecting brain circuitry with electric
More informationMedication for Anxiety and Depression. PJ Cowen Department of Psychiatry, University of Oxford
Medication for Anxiety and Depression PJ Cowen Department of Psychiatry, University of Oxford Topics Medication for anxiety disorders Medication for first line depression treatment Medication for resistant
More informationThe Next Chapter in Brain Stimulation Therapy
The Next Chapter in Brain Stimulation Therapy Outline I. Depression and Treatment Resistant Depression Barriers to Treatment Treatment Options Cost and Impact of Depression II. Electroconvulsive Therapy
More informationClinical Commissioning Policy: Deep Brain Stimulation for Refractory Epilepsy (all ages) NHS England Reference: P
Clinical Commissioning Policy: Deep Brain Stimulation for Refractory Epilepsy (all ages) NHS England Reference: 1736P NHS England INFORMATION READER BOX Directorate Medical Operations and Information
More informationSEEING KETAMINE IN A NEW LIGHT
SEEING KETAMINE IN A NEW LIGHT BobbieJean Sweitzer, M.D., FACP Professor of Anesthesiology Director of Perioperative Medicine Northwestern University Bobbie.Sweitzer@northwestern.edu LEARNING OBJECTIVES
More information2018 Otsuka Pharmaceutical Development & Commercialization, Inc., Rockville, MD Lundbeck, LLC.
Neuromodulation Techniques: State of the Science Philip G. Janicak, MD Adjunct Professor Department of Psychiatry and Behavioral Sciences, Northwestern University Feinberg School of Medicine Consultant
More informationAnatomy of a Neuron. Copyright 2000 by BSCS and Videodiscovery, Inc. Permission granted for classroom use. Updated Master 2.
Anatomy of a Neuron Master 2.1 Neurons Interact with Other Neurons through Synapses Master 2.2 Name Date Due Cells of the Nervous System Learning Target: Identify and state the function of the components
More informationTreatment of Depression: A Brief History
2500 82nd Place Urbandale, Ia Treatment of Depression: A Brief History 1960 s to Present Community Based Services SSRI Antidepressants SNRI Antidepressants 1970 s to present 20% of patients do not respond
More informationSupplemental Data. Inclusion/exclusion criteria for major depressive disorder group and healthy control group
1 Supplemental Data Inclusion/exclusion criteria for major depressive disorder group and healthy control group Additional inclusion criteria for the major depressive disorder group were: age of onset of
More informationNeuromodulation in Epilepsy. Gregory C. Mathews, M.D., Ph.D.
Neuromodulation in Epilepsy Gregory C. Mathews, M.D., Ph.D. Disclosure There are no disclosures to share with regards to this presentation. Epilepsy Basics What is epilepsy? Partial versus generalized
More informationUnderstanding Addiction and Its Impact on the Brain. SDSMA Webinar Matthew Stanley, DO
Understanding Addiction and Its Impact on the Brain SDSMA Webinar Matthew Stanley, DO Estimated Economic Cost to Society Due to Substance Abuse and Addiction: Illegal drugs: Alcohol: Tobacco: $181 billion/year
More informationStimulation and/or Surgical Approaches to Psychiatric Illness
Stimulation and/or Surgical Approaches to Psychiatric Illness Darin D. Dougherty, MD MMSc Director, Division of Neurotherapeutics Department of Psychiatry Massachusetts General Hospital Associate Professor
More informationrtms Versus ECT The Future of Neuromodulation & Brain Stimulation Therapies
rtms Versus ECT The Future of Neuromodulation & Brain Stimulation Therapies rtms Treatment Equipment rtms Equipment Positioning of coil ECT & rtms Innovative Treatment Options for Patients Only a fraction
More informationStimulation and/or Surgical Approaches to Psychiatric Illness
Stimulation and/or Surgical Approaches to Psychiatric Illness Darin D. Dougherty, MD MMSc Director, Division of Neurotherapeutics Department of Psychiatry Massachusetts General Hospital Associate Professor
More informationNeurotransmitter Functioning In Major Depressive Disorder
Neurotransmitter Functioning In Major Depressive Disorder Otsuka Pharmaceutical Development & Commercialization, Inc. 2017 Otsuka Pharmaceutical Development & Commercialization, Inc., Rockville, MD January
More informationInpatient Quality Reporting (IQR) Program
Hypotension Inpatient Quality Reporting (IQR) Program SEP-1 Early Management Bundle, Severe Sepsis/ Septic Shock: v5.1 Measure Updates Questions and Answers Moderator: Candace Jackson, RN Project Lead,
More informationRepetitive Transcranial Magnetic Stimulation (rtms) and intravenous ketamine for treatment-resistant depression (TRD)
Repetitive Transcranial Magnetic Stimulation (rtms) and intravenous ketamine for treatment-resistant depression (TRD) Docent, Senior Pychiatrist Tero Taiminen Unit of General Hospital Psychiatry Turku
More informationShaheen Shaikh, M.D. Assistant Professor of Anesthesiology, University of Massachusetts Medical center, Worcester, MA.
Shaheen Shaikh, M.D. Assistant Professor of Anesthesiology, University of Massachusetts Medical center, Worcester, MA. Shobana Rajan, M.D. Associate staff Anesthesiologist, Cleveland Clinic, Cleveland,
More informationPsychoactive Drugs & The Brain
Psychoactive Drugs & The Brain Psychoactive Substances & The Brain 1. Psychoactive substances enter the bloodstream via oral administration, inhalation, smoking, or injection 2. Psychoactive substances
More informationKetamine in Psychiatric Practice: Taking the Long-Term View
Ketamine in Psychiatric Practice: Taking the Long-Term View Sanjay J. Mathew, MD Professor of Psychiatry & Behavioral Sciences Johnson Family Chair for Research in Psychiatry Menninger Department of Psychiatry
More informationCell body, axon, dendrite, synapse
SOME BASIC NEUROSCIENCE Neurons have specialised extensions 1: Label the parts of a neuron by selecting the correct term from the box below. Cell body, axon, dendrite, synapse 1 dendrite synapse cell body
More informationSubthalamic Nucleus Deep Brain Stimulation (STN-DBS)
Subthalamic Nucleus Deep Brain Stimulation (STN-DBS) A Neurosurgical Treatment for Parkinson s Disease Parkinson s Disease Parkinson s disease is a common neurodegenerative disorder that affects about
More informationThe Neurobiology of Schizophrenia
The Neurobiology of Schizophrenia Dost Ongur, MD PhD Neither I nor my spouse/partner has a relevant financial relationship with a commercial interest to disclose. What is Psychosis? Response Language Affect
More information9/19/2018. Conflict of Interest Author Disclosure. Educational Objectives
Health Coaching to Increase Participation in Online Chronic Pain Management Programs: Lessons Learned Teresa Bigand, PhD-C, MSN, RN Marian Wilson, PhD, MPH, RN Mary Roberts, PhD, BSN, RN Jamie Lewis, MD
More informationZinging the Blues. By Kathy Svitil
Zinging the Blues By Kathy Svitil By using magnetic or electrical stimulation to alter neural activity in the brain, neuromodulation joins medications and psychotherapy as a third domain for the treatment
More informationBarbara K. Wolicki BSN, RN Immunization Nurse Consultant MDCH Division of Immunization
Barbara K. Wolicki BSN, RN Immunization Nurse Consultant MDCH Division of Immunization WolickiB@michigan.gov Immunization Process Assess the Immunization Record Check the Recommended Schedule Ask the Screening
More informationCharles H. Kellner, MD
ECT: Learning From Recent Trials Charles H. Kellner, MD Professor, Department of Psychiatry Icahn School of Medicine at Mount Sinai ISCTM Philadelphia, PA 27 September, 2016 Charles H. Kellner, MD Disclosures
More informationBasal Ganglia. Steven McLoon Department of Neuroscience University of Minnesota
Basal Ganglia Steven McLoon Department of Neuroscience University of Minnesota 1 Course News Graduate School Discussion Wednesday, Nov 1, 11:00am MoosT 2-690 with Paul Mermelstein (invite your friends)
More informationHallucinogens as Treatment? Preliminary Data with Ketamine. Elias Dakwar, MD Columbia University College of Physicians and Surgeons 19 October, 2017
Hallucinogens as Treatment? Preliminary Data with Ketamine Elias Dakwar, MD Columbia University College of Physicians and Surgeons 19 October, 2017 Disclosures Elias Dakwar has received funding from NIDA
More informationAction Potentials and Synaptic Transmission. BIO 219 Napa Valley College Dr. Adam Ross
Action Potentials and Synaptic Transmission BIO 219 Napa Valley College Dr. Adam Ross Review of action potentials Nodes of Ranvier Nucleus Dendrites Cell body In saltatory conduction, the nerve impulses
More informationPrimary Care: Referring to Psychiatry
Primary Care: Referring to Psychiatry Carol Capitano, PhD, APRN-BC Assistant Professor, Clinical Educator University of New Mexico College of Nursing University of New Mexico Psychiatric Center Objectives
More informationThe Role of Ketamine in Depression: By Mary Garner. Background: Introduction
The Role of Ketamine in Depression: By Mary Garner Background: Introduction The average person has up to 15% lifetime risk for developing depression 13. Major depressive disorder symptoms can include a
More informationPatient Manual Brainsway Deep Transcranial Magnetic Stimulation (Deep TMS) System for Treatment of Major Depressive Disorder
Dr. Zahida Tayyib www.mvptms.com Patient Manual Brainsway Deep Transcranial Magnetic Stimulation (Deep TMS) System for Treatment of Major Depressive Disorder If you are considering Brainsway Deep treatment
More informationALCOHOL Other name(s): ethyl alcohol, ethanol, grain alcohol, hootch, liquor, booze, firewater, EtOH Class: alcohols are molecules with a hydroxyl
Other name(s): ethyl alcohol, ethanol, grain alcohol, hootch, liquor, booze, firewater, EtOH Class: alcohols are molecules with a hydroxyl (OH) bound to carbon atoms. In EtOH, the carbon is in an ethyl
More informationFebruary 23, Q4 and Year-End 2016 Financial Results
February 23, 2017 Q4 and Year-End 2016 Financial Results 2 RETHINKING CNS Agenda Today s Speakers Paul Cox, Senior Director, Investor Relations Jeff Jonas, M.D., Chief Executive Officer Jim Doherty, Ph.D.,
More informationAre you not responding to antidepressants?
PATIENTS & RELATIVES Are you not responding to antidepressants? TMS therapy might be the solution for you. Does not affect cognitive function No anesthesia Covered by most private providers Outpatient
More informationNational Institute on Drug Abuse (NIDA) Understanding Drug Abuse and Addiction: What Science Says
National Institute on Drug Abuse (NIDA) Understanding Drug Abuse and Addiction: What Science Says Last Updated February 2016 https://www.drugabuse.gov 1 Table of Contents Understanding Drug Abuse and Addiction:
More informationLowering epilepsy-related treatment costs in the era of patient choice and value-based care
Lowering epilepsy-related treatment costs in the era of patient choice and value-based care In-home EEG offers cost-effective, reliable alternative to traditional diagnostic services 01 Introduction One
More informationAddiction in the Brain - Latest Research. Gary M. Henschen, MD, LFAPA Chief Behavioral Health Officer Magellan Healthcare, Inc.
Addiction in the Brain - Latest Research Gary M. Henschen, MD, LFAPA Chief Behavioral Health Officer Magellan Healthcare, Inc. The Neurobiology of Addiction About the speaker Gary M. Henschen, M.D. is
More informationFor more information about how to cite these materials visit
Author: Michael Jibson, M.D., Ph.D., 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution Share Alike 3.0 License: http://creativecommons.org/licenses/by-sa/3.0/
More informationInsights. Resources for Physicians. Resources for Patients. Referrals. Revealing the Underlying Neural Mechanisms of Successful ECT
The Cleveland Clinic Foundation 9500 Euclid Avenue / AC311 Cleveland, OH 44195 A publication of the Center for Behavioral Health Resources for Physicians Physician Directory View all Cleveland Clinic staff
More informationTranscranial Magnetic Stimulation for the Treatment of Depression
Transcranial Magnetic Stimulation for the Treatment of Depression Paul E. Holtzheimer, MD Associate Professor Departments of Psychiatry and Surgery Geisel School of Medicine at Dartmouth Dartmouth-Hitchcock
More informationDelirium Monograph - Update, Spring 2014
Delirium Monograph - Update, Spring 2014 Since publication of the APM monograph on Delirium in January 2012, three structured reviews have been published adding data relevant to the practice of identification,
More informationTreating Depressed Patients with Comorbid Trauma. Lori Higa BSN, RN-BC AIMS Consultant/Trainer
Treating Depressed Patients with Comorbid Trauma Lori Higa BSN, RN-BC AIMS Consultant/Trainer Learning Objectives By the end of this training, participants should be able to: Discuss recent trends in trauma
More informationEffects of acute ketamine infusion on visual working memory encoding: a study using ERPs
Effects of acute ketamine infusion on visual working memory encoding: a study using ERPs Corinna Haenschel Psychology, City University London, UK Partly Funded by: the Welsh Institute of Cognitive Neuroscience
More informationWhen & How to Use ECT in Older Adults. Frans Hugo SJOG Midland Hospital, PERTH
When & How to Use ECT in Older Adults Frans Hugo SJOG Midland Hospital, PERTH Frans.Hugo@sjog.org.au When to Use Most effective and rapid treatment for elderly with severe MDD, bipolar mania, bipolar depression
More informationPractice and Potential of Deep Brain Stimulation
Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/medical-breakthroughs-from-penn-medicine/practice-and-potential-ofdeep-brain-stimulation/3384/
More informationHealthTalks. Deep Brain Stimulation for Parkinson s Disease Patients
HealthTalks Parkinson s Disease and Wellness Ali Rezai, MD Neurological Institute Director, Center for Neurological Restoration Cleveland Clinic Appointments: 216.444.4720 Deep Brain Stimulation for Parkinson
More informationThe Benefits of Ketamine in the Prehospital Environment by Appropriately Trained Professionals July 2016 Sean Eaton, FP-C
The Benefits of Ketamine in the Prehospital Environment by Appropriately Trained Professionals July 2016 Sean Eaton, FP-C Introduction First introduced in the 1960 s as an alternative to PCP for anesthesia
More informationsubstance use and mental disorders: one, the other, or both?
substance use and mental disorders: one, the other, or both? Stephen Strobbe, PhD, RN, PMHCNS-BC, CARN-AP Dawn Farm Education Series St. Joe s Education Center, Ypsilanti, MI Tuesday, January 27, 2015
More information